Ping Chen
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- Ubiquitin and proteasome pathways 17
- RNA modifications and cancer 9
-
- Cancer-related molecular mechanisms research 10
- Cancer, Hypoxia, and Metabolism 9
- MicroRNA in disease regulation 6
- Co-authors
- Tao Hu (14 shared papers)Simon Bergqvist (4 shared papers)Ziming Dong (8 shared papers)James Register (4 shared papers)Patrick M. O’Connor (2 shared papers)Zhuqing Jia (3 shared papers)Chunyan Zhou (3 shared papers)Kangtao Ma (3 shared papers)
- Journals
- Cell Death and Disease (4 papers)Oncotarget (4 papers)APOPTOSIS (3 papers)Cancer Research (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ping Chen
123 papers receiving 3.4k citations
Ping Chen's Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 618
- Oncology 761
- Molecular Biology 2.0k
- Cell Biology 282
- Pathology and Forensic Medicine 208
Countries citing papers authored by Ping Chen
This map shows the geographic impact of Ping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Chen more than expected).
Fields of papers citing papers by Ping Chen
This network shows the impact of papers produced by Ping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Chen. The network helps show where Ping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance Hit paper breakdown → | 2016 | 328 |
| 2 | 2008 | 178 | |
| 3 | 2000 | 167 | |
| 4 | 2019 | 141 | |
| 5 | 1996 | 133 | |
| 6 | 2002 | 127 | |
| 7 | 2014 | 105 | |
| 8 | 2015 | 92 | |
| 9 | 2018 | 87 | |
| 10 | 2011 | 76 | |
| 11 | 1992 | 73 | |
| 12 | 2012 | 68 | |
| 13 | 1995 | 66 | |
| 14 | 2015 | 64 | |
| 15 | 2017 | 64 | |
| 16 | 2017 | 62 | |
| 17 | 2016 | 60 | |
| 18 | 2018 | 60 | |
| 19 | 2010 | 59 | |
| 20 | 2015 | 55 |
About Ping Chen
Ping Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Materials Chemistry and Pulmonary and Respiratory Medicine, having authored 126 papers that have together received 3.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (17 papers), Cancer-related Molecular Pathways (11 papers), Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers), Cancer, Hypoxia, and Metabolism (9 papers), Photodynamic Therapy Research Studies (8 papers), Autophagy in Disease and Therapy (7 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (618 citations), Oncology (761 citations), Molecular Biology (2.0k citations), Cell Biology (282 citations) and Pathology and Forensic Medicine (208 citations). Ping Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Tao Hu, Simon Bergqvist, Ziming Dong, James Register, Patrick M. O’Connor, Zhuqing Jia, Chunyan Zhou, Kangtao Ma, Chen‐Chen Kan and Stephen A. Margosiak. Their work appears in journals such as Cell Death and Disease, Oncotarget, APOPTOSIS, Cancer Research and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.